Regulus Therapeutics
Regulus Therapeutics – A Leading microRNA Therapeutics Company | Regulus Therapeutics – a leading company developing microRNA therapeutics. Medicines that target the pathways of human disease..
Launch date
Employees
Market cap
€95.8m
Enterprise valuation
€11m (Public information from Sep 2024)
Share price
$1.71 RGLS
San Diego California (HQ)
Authorizing premium user...